Publications for Humayun Islam

Amin, A., Safaya, A., Ronny, F., Islam, H., Bhuta, K., & Rajdeo, H. (2016). Hemorrhagic shock from spontaneous splenic rupture requiring open splenectomy in a patient taking rivaroxaban. The American Surgeon, 82(2), E54-E55.

Babayeva, S., Huang, W., Islam, H., Fallon, J. T., & Zhong, M. (2016). Detection gene fusion(s) in melanotic Xp11 translocation renal cancer by RNA-seq. Laboratory Investigation, 96(Suppl 1), 215A.

Babayeva, S., Huang, W., Islam, H., Fallon, J. T., & Zhong, M. (2016). Detection gene fusion(s) in melanotic Xp11 translocation renal cancer by RNA-seq. Modern Pathology, 29(Suppl 2), 215A.

Katchi, T., Kolandaivel, K., Khattar, P., Farooq, T., Islam, H., & Liu, D. (2016). Extramedullary hematopoiesis presented as cytopenia and massive paraspinal masses leading to cord compression in a patient with hereditary persistence of fetal hemoglobin. Biomarker Research, 4(1), 17. doi:10.1186/s40364-016-0071-6

Levendoglu-Tugal, O., Pinto, A., & Islam, H. (2016). Hemophagocytic lymphohistiocytosis in an infant with Kabuki syndrome. Pediatric Blood & Cancer, 63(Suppl S2), S46.

Mamorska-Dyga, A., Ronny, F. M., Puccio, C., Islam, H., & Liu, D. (2016). A rare case of the upper extremity diffuse large B-cell lymphoma mimicking soft tissue sarcoma in an elderly patient. Stem Cell Investigation, 3, 25. doi:10.21037/sci.2016.06.06

Mamorska-Dyga, A., Wu, J., Khattar, P., Ronny, F. M., Islam, H., Seiter, K., & Liu, D. (2016). Acute promyelocytic leukemia co-existing with JAK2 V617F positive myeloproliferative neoplasm: A case report. Stem Cell Investigation, 3, 8. doi:10.21037/sci.2016.03.02

Vail, E., Yoon, E., & Islam, H. (2016). Response of prospective residents to an updated departmental website at a mid-size academic medical center, an updated report. American Journal of Clinical Pathology, 146(Suppl 1), 135. doi:10.1093/ajcp/aqw150.009

Awasthi, A., Ayello, J., Van De Ven, C., Elmacken, M., Sabulski, A., Islam, H., . . . Cairo, M. S. (2015). Obinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody-dependent cytotoxicity and improves overall survival against CD20 rituximab-sensitive/-resistant Burkitt lymphoma (BL) and precursor B-acute lymphoblastic leukaemia (pre-B-ALL): Potential targeted therapy in patients with poor risk CD20 BL and pre-B-ALL. British Journal of Haematology, 171(5), 763-775. doi:10.1111/bjh.13764